Bristol-Myers Squibb (BMY) Earnings Date, Estimates & Call Transcripts $46.58 -1.60 (-3.32%) As of 05/13/2025 03:59 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Bristol-Myers Squibb Earnings Summary Bristol-Myers Squibb released Q1 2025 earnings on April 24, 2025, reporting an EPS of $1.80, which topped analysts' consensus estimates of $1.50 by $0.30. Quarterly revenue fell 5.6% year-over-year to $11.20 billion, above analyst estimates of $10.77 billion. With a trailing EPS of $2.67, Bristol-Myers Squibb's earnings are expected to decrease -9.64% next year, from $6.74 to $6.09 per share. Upcoming Q2 Earnings DateJul. 25Before Market OpensEstimatedConsensus EPS (Apr. 24) $1.50 Actual EPS (Apr. 24) $1.80 Beat By $0.30 Actual Revenue (Apr. 24) $11.20BQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Quarterly Report (10-Q)SEC FilingBMY Upcoming EarningsBristol-Myers Squibb's next earnings date is estimated for Friday, July 25, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Bristol-Myers Squibb Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bristol-Myers Squibb and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBMY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BMY Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Bristol-Myers Squibb Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20252$1.55$1.59$1.57Q2 20253$1.52$1.69$1.62Q3 20253$1.69$1.87$1.75Q4 20253$1.65$1.79$1.71 FY 2025 11 $6.41 $6.94 $6.66 Q1 20262$1.41$1.53$1.47Q2 20262$1.50$1.53$1.52Q3 20262$1.52$1.63$1.58Q4 20262$1.36$1.41$1.39 FY 2026 8 $5.79 $6.10 $5.95 Q1 20271$1.41$1.41$1.41 Bristol-Myers Squibb Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 7/25/2025(Estimated)--------4/24/2025Q1 2025$1.50$1.80+$0.30$1.21$10.77B$11.20B2/6/2025Q4 2024$1.47$1.67+$0.20$0.04$11.57B-10/31/2024Q3 2024$1.49$1.80+$0.31$3.00$11.26B$11.89B7/26/2024Q2 2024$1.64$2.07+$0.43$3.31$11.54B$12.20B4/25/2024Q1 2024-$4.53-$4.40+$0.13$9.69$11.45B$11.87B2/2/2024Q4 2023$1.55$1.70+$0.15$2.53$11.19B$11.48B10/26/2023Q3 2023$1.76$2.00+$0.24$3.07$10.96B$10.97B7/27/2023Q2 2023$1.99$1.75 -$0.24$2.51$11.81B$11.23B Bristol-Myers Squibb Earnings - Frequently Asked Questions When is Bristol-Myers Squibb's earnings date? Bristol-Myers Squibb has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, July 25th, 2025 based off last year's report dates. Learn more on BMY's earnings history. What guidance has Bristol-Myers Squibb issued on next quarter's earnings? Bristol-Myers Squibb updated its FY 2025 earnings guidance on Thursday, April, 24th. The company provided earnings per share guidance of 6.700-7.000 for the period, compared to the consensus earnings per share estimate of 6.740. The company issued revenue guidance of $45.8 billion-$46.8 billion, compared to the consensus revenue estimate of $45.8 billion. Did Bristol-Myers Squibb beat their earnings estimates last quarter? In the previous quarter, Bristol-Myers Squibb (NYSE:BMY) reported $1.80 earnings per share (EPS) to beat the analysts' consensus estimate of $1.50 by $0.30. Learn more on analysts' earnings estimate vs. BMY's actual earnings. How can I listen to Bristol-Myers Squibb's earnings conference call? The conference call for Bristol-Myers Squibb's latest earnings report can be listened to online. Listen to Conference Call How can I read Bristol-Myers Squibb's conference call transcript? The conference call transcript for Bristol-Myers Squibb's latest earnings report can be read online. Read Transcript How can I view Bristol-Myers Squibb's earnings report? Bristol-Myers Squibb's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Bristol-Myers Squibb generate each year? Bristol-Myers Squibb (NYSE:BMY) has a recorded annual revenue of $47.64 billion. How much profit does Bristol-Myers Squibb generate each year? Bristol-Myers Squibb (NYSE:BMY) has a recorded net income of -$8.95 billion. BMY has generated $2.67 earnings per share over the last four quarters. What is Bristol-Myers Squibb's price-to-earnings ratio? Bristol-Myers Squibb (NYSE:BMY) has a forward price-to-earnings ratio of 6.91. The price/earnings-to-growth ratio is 2.07. What is Bristol-Myers Squibb's EPS forecast for next year? Bristol-Myers Squibb's earnings are expected to decrease from $6.74 per share to $6.09 per share in the next year, which is a -9.64% change. More Earnings Resources from MarketBeat Related Companies JNJ Earnings Date ABBV Earnings Date MRK Earnings Date PFE Earnings Date ZTS Earnings Date RPRX Earnings Date CORT Earnings Date JAZZ Earnings Date PRGO Earnings Date SUPN Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum HoldsWhy Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery?Datadog Earnings Delight: Q1 Strength and an Upbeat Forecast Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming? This page (NYSE:BMY) was last updated on 5/14/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s third-term comments grabbed headlines, but the bigger story is what he’s planning next. A new report ...Porter & Company | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredA New Economic Shift – How You Can PrepareWhile everyone's focused on the Fed and interest rates... most investors are missing the real story. There'...InvestorPlace | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredDrop these 5 stocks now!You think the volatility is over? Think again … Because it’s just getting started. In fact, according...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. Share Bristol-Myers Squibb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
